• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨钙素与胰岛素抵抗及非酒精性脂肪性肝病组织病理学变化的关系。

Relation of osteocalcin with insulin resistance and histopathological changes of non alcoholic fatty liver disease.

机构信息

Center of Investigation of Endocrinology and Clinical Nutrition, Medicine School and Unit of Investigation, Hospital Rio Hortega, University of Valladolid, Spain.

出版信息

Ann Hepatol. 2011 Jan-Mar;10(1):50-5.

PMID:21301010
Abstract

BACKGROUND

Osteocalcin is a hormone with a complex cross-talk between adipose tissue and the skeleton. The aim of the present study was to explore the relation of osteocalcin with histopathological changes of NALFD patients.

SUBJECTS

A population of 69 NAFLD patients was analyzed. A liver biopsy was realized. Weight, fat mass, body mass index, basal glucose, insulin, insulin resistance (HOMA), total cholesterol, LDLcholesterol, HDL-cholesterol, triglycerides and osteocalcin levels were measured.

RESULTS

Patients were divided in two groups by median osteocalcin value (11.34 ng/mL), group I (patients with the low values) and group II (patients with the high values). Only liver fibrosis frequencies were different between groups (group I: 22.9% vs group II: 9.4%; p < 0.05). Patients in group I had higher levels of glucose (115.6 ± 28.1 mg/dL vs. 103.7 ± 24.3 mg/dL; p < 0.04), HOMA (4.6 ± 3.1 units vs. 3.6 ± 1.8 units; p < 0.04), weight (102.9 ± 32.4 kg vs. 85.9 ± 16.8 kg; p = 0.002) and body mass index (38.3 ± 11.4 kg/m(2) vs. 30.1 ± 5.7 kg/m(2); p = 0.001)) than patients in group II. Osteocalcin was inverse correlated with glucose (r =-0.4; p = 0.002) and HOMA (r = -0.3:p = 0.01).

CONCLUSION

Osteocalcin is associated with liver fibrosis. However, this association disappeared in a multivariate analysis, and HOMA remained as an independent factor.

摘要

背景

骨钙素是一种具有脂肪组织和骨骼之间复杂串扰的激素。本研究旨在探讨骨钙素与 NALFD 患者组织病理学变化的关系。

受试者

分析了 69 名非酒精性脂肪性肝病患者。进行了肝活检。测量体重、脂肪量、体重指数、基础血糖、胰岛素、胰岛素抵抗(HOMA)、总胆固醇、LDL 胆固醇、HDL 胆固醇、甘油三酯和骨钙素水平。

结果

根据骨钙素中位数(11.34ng/ml)将患者分为两组,I 组(低值组)和 II 组(高值组)。仅肝纤维化频率在两组之间存在差异(I 组:22.9% vs. II 组:9.4%;p<0.05)。I 组患者的血糖(115.6±28.1mg/dL 与 103.7±24.3mg/dL;p<0.04)、HOMA(4.6±3.1 单位与 3.6±1.8 单位;p<0.04)、体重(102.9±32.4kg 与 85.9±16.8kg;p=0.002)和体重指数(38.3±11.4kg/m2 与 30.1±5.7kg/m2;p=0.001)均高于 II 组。骨钙素与血糖呈负相关(r=-0.4;p=0.002)和 HOMA(r=-0.3;p=0.01)。

结论

骨钙素与肝纤维化相关。然而,这种相关性在多变量分析中消失,HOMA 仍然是一个独立的因素。

相似文献

1
Relation of osteocalcin with insulin resistance and histopathological changes of non alcoholic fatty liver disease.骨钙素与胰岛素抵抗及非酒精性脂肪性肝病组织病理学变化的关系。
Ann Hepatol. 2011 Jan-Mar;10(1):50-5.
2
Influence of visfatin on histopathological changes of non-alcoholic fatty liver disease.内脂素对非酒精性脂肪性肝病组织病理学变化的影响。
Dig Dis Sci. 2009 Aug;54(8):1772-7. doi: 10.1007/s10620-008-0539-9. Epub 2008 Nov 14.
3
Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease.在非酒精性脂肪性肝病的非糖尿病患者中,胰岛素抵抗而非内脏脂肪指数与肝纤维化相关。
Metab Syndr Relat Disord. 2015 Sep;13(7):319-25. doi: 10.1089/met.2015.0018. Epub 2015 May 26.
4
Clinical Study of Serum Homocysteine and Non-Alcoholic Fatty Liver Disease in Euglycemic Patients.血糖正常患者血清同型半胱氨酸与非酒精性脂肪性肝病的临床研究
Med Sci Monit. 2016 Nov 2;22:4146-4151. doi: 10.12659/msm.897924.
5
Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.负荷后胰岛素抵抗是丙型病毒性肝炎和非酒精性脂肪性肝病中肝纤维化的独立预测指标。
Gut. 2007 Sep;56(9):1296-301. doi: 10.1136/gut.2006.107946. Epub 2007 Mar 28.
6
Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.非酒精性脂肪性肝病超重/肥胖儿童的胰腺脂肪与β细胞功能
World J Gastroenterol. 2015 Apr 21;21(15):4688-95. doi: 10.3748/wjg.v21.i15.4688.
7
Plasminogen activator inhibitor type 1 serum levels and 4G/5G gene polymorphism in morbidly obese Hispanic patients with non-alcoholic fatty liver disease.纤溶酶原激活物抑制剂-1 血清水平与非酒精性脂肪性肝病肥胖 Hispanic 患者 4G/5G 基因多态性的关系。
Ann Hepatol. 2011 Oct-Dec;10(4):493-501.
8
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.非酒精性脂肪性肝病患者转氨酶水平正常时发生严重肝病的风险:胰岛素抵抗和糖尿病的作用
Hepatology. 2008 Sep;48(3):792-8. doi: 10.1002/hep.22429.
9
Influence of insulin resistance and adipokines in the grade of steatosis of nonalcoholic fatty liver disease.胰岛素抵抗和脂肪因子对非酒精性脂肪性肝病脂肪变性程度的影响。
Dig Dis Sci. 2008 Apr;53(4):1088-92. doi: 10.1007/s10620-007-9981-3. Epub 2007 Oct 13.
10
Response of osteocalcin and insulin resistance after a hypocaloric diet in obese patients.肥胖患者低热量饮食后骨钙素及胰岛素抵抗的反应
Eur Rev Med Pharmacol Sci. 2015 Jun;19(12):2174-9.

引用本文的文献

1
Osteokines in Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病中的成骨细胞因子。
Curr Obes Rep. 2024 Dec;13(4):703-723. doi: 10.1007/s13679-024-00586-9. Epub 2024 Sep 3.
2
Decreased Serum Osteocalcin is an Independent Risk Factor for Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes.血清骨钙素降低是2型糖尿病中代谢功能障碍相关脂肪性肝病的独立危险因素。
Diabetes Metab Syndr Obes. 2022 Nov 29;15:3717-3728. doi: 10.2147/DMSO.S389794. eCollection 2022.
3
Bone Turnover Markers and Probable Advanced Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Men and Postmenopausal Women With Type 2 Diabetes.
2型糖尿病中老年男性和绝经后女性的骨转换标志物与可能的晚期非酒精性脂肪性肝病
Front Endocrinol (Lausanne). 2020 Jan 28;10:926. doi: 10.3389/fendo.2019.00926. eCollection 2019.
4
Association of Nonalcoholic Fatty Liver Disease With Osteoporotic Fractures: A Cross-Sectional Retrospective Study of Chinese Individuals.非酒精性脂肪性肝病与骨质疏松性骨折的关联:一项针对中国人群的横断面回顾性研究。
Front Endocrinol (Lausanne). 2018 Jul 23;9:408. doi: 10.3389/fendo.2018.00408. eCollection 2018.
5
Reduced Serum IGF-1 Associated With Hepatic Osteodystrophy Is a Main Determinant of Low Cortical but Not Trabecular Bone Mass.血清 IGF-1 降低与肝性骨营养不良相关,是皮质骨而非小梁骨骨量低的主要决定因素。
J Bone Miner Res. 2018 Jan;33(1):123-136. doi: 10.1002/jbmr.3290. Epub 2017 Nov 6.
6
Non-alcoholic fatty liver disease connections with fat-free tissues: A focus on bone and skeletal muscle.非酒精性脂肪性肝病与无脂肪组织的关联:聚焦骨骼与骨骼肌
World J Gastroenterol. 2017 Mar 14;23(10):1747-1757. doi: 10.3748/wjg.v23.i10.1747.
7
Association of nonalcoholic fatty liver disease with bone mineral density and serum osteocalcin levels in Korean men.韩国男性非酒精性脂肪性肝病与骨密度及血清骨钙素水平的关联
Eur J Gastroenterol Hepatol. 2016 Mar;28(3):338-44. doi: 10.1097/MEG.0000000000000535.
8
Inverse relationship between serum osteocalcin levels and nonalcoholic fatty liver disease in postmenopausal Chinese women with normal blood glucose levels.血糖正常的绝经后中国女性血清骨钙素水平与非酒精性脂肪性肝病的负相关关系。
Acta Pharmacol Sin. 2015 Dec;36(12):1497-502. doi: 10.1038/aps.2015.81. Epub 2015 Nov 16.
9
Relationships between the Osteocalcin gene polymorphisms, serum osteocalcin levels, and hepatitis B virus-related hepatocellular carcinoma in a Chinese population.中国人群中骨钙素基因多态性、血清骨钙素水平与乙型肝炎病毒相关肝细胞癌的关系。
PLoS One. 2015 Jan 14;10(1):e0116479. doi: 10.1371/journal.pone.0116479. eCollection 2015.
10
Osteocalcin protects against nonalcoholic steatohepatitis in a mouse model of metabolic syndrome.骨钙素在代谢综合征小鼠模型中可预防非酒精性脂肪性肝炎。
Endocrinology. 2014 Dec;155(12):4697-705. doi: 10.1210/en.2014-1430. Epub 2014 Oct 3.